Literature DB >> 14602785

Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes.

Vinaya Simha1, Abhimanyu Garg.   

Abstract

Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive syndrome characterized by extreme paucity of adipose tissue since birth, acanthosis nigricans, severe insulin resistance, marked hypertriglyceridemia, and early-onset diabetes mellitus. Recently, we reported mutations in the 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) gene in CGL pedigrees linked to chromosome 9q34 (CGL1 subtype), and mutations in the Seipin gene were reported in pedigrees linked to chromosome 11q13 (CGL2 subtype). Whether the two subtypes have differences in body fat distribution has not been investigated. We, therefore, compared whole-body adipose tissue distribution by magnetic resonance imaging in 10 CGL patients, of whom seven (six females, one male) had CGL1 and three (two males, one female) had CGL2. Both subtypes had marked lack of metabolically active adipose tissue located at most sc, intermuscular, bone marrow, intraabdominal, and intrathoracic regions. Paucity of mechanical adipose tissue in the palms, soles, orbits, scalp, and periarticular regions was noted in CGL2, whereas it was well preserved in CGL1 patients. We conclude that CGL patients with Seipin mutations have a more severe lack of body fat, which affects both metabolically active and mechanical adipose tissue, compared with patients with mutations in the AGPAT2 gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602785     DOI: 10.1210/jc.2003-030835

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  53 in total

Review 1.  [Adipose tissue. Cellular and molecular principles].

Authors:  S Grether-Beck; J Krutmann
Journal:  Hautarzt       Date:  2010-10       Impact factor: 0.751

Review 2.  Lipodystrophy: pathophysiology and advances in treatment.

Authors:  Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

3.  Berardinelli-Seip lipodystrophy.

Authors:  Yuko Kobashi; Amy Schoenbaum; Robert P Hasserjian; Daniel I Rosenthal
Journal:  Skeletal Radiol       Date:  2007-06-07       Impact factor: 2.199

Review 4.  What the genetics of lipodystrophy can teach us about insulin resistance and diabetes.

Authors:  Camille Vatier; Guillaume Bidault; Nolwenn Briand; Anne-Claire Guénantin; Laurence Teyssières; Olivier Lascols; Jacqueline Capeau; Corinne Vigouroux
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

5.  Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases.

Authors:  Stephanie Teboul-Coré; Caroline Rey-Jouvin; Anne Miquel; Camille Vatier; Jacqueline Capeau; Jean-Jacques Robert; Thao Pham; Olivier Lascols; Francis Berenbaum; Jean-Denis Laredo; Corinne Vigouroux; Jérémie Sellam
Journal:  Skeletal Radiol       Date:  2016-09-08       Impact factor: 2.199

Review 6.  Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-11-08       Impact factor: 4.810

7.  Caveolin-1: a new locus for human lipodystrophy.

Authors:  Abhimanyu Garg; Anil K Agarwal
Journal:  J Clin Endocrinol Metab       Date:  2008-04       Impact factor: 5.958

Review 8.  Pediatric obesity phenotyping by magnetic resonance methods.

Authors:  Wei Shen; Haiying Liu; Mark Punyanitya; Jun Chen; Steven B Heymsfield
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2005-11       Impact factor: 4.294

Review 9.  Seipin: from human disease to molecular mechanism.

Authors:  Bethany R Cartwright; Joel M Goodman
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

10.  Congenital generalized lipodystrophy in an Indian patient with a novel mutation in BSCL2 gene.

Authors:  H U Shirwalkar; Z M Patel; J Magre; P Hilbert; L Van Maldergem; R R Mukhopadhyay; A Maitra
Journal:  J Inherit Metab Dis       Date:  2008-08-12       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.